Net Cash Provided by (Used in) Financing Activities in USD of GILEAD SCIENCES, INC. from Q1 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
GILEAD SCIENCES, INC. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from Q1 2010 to Q1 2025.
  • GILEAD SCIENCES, INC. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was -$3.43B, a 152% decline year-over-year.
  • GILEAD SCIENCES, INC. annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$3.43B, a 33% increase from 2023.
  • GILEAD SCIENCES, INC. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$5.13B, a 20.8% increase from 2022.
  • GILEAD SCIENCES, INC. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$6.47B, a 27.1% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

GILEAD SCIENCES, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$3.43B -$2.07B -152% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025
Q1 2024 -$1.36B +$45M +3.2% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025
Q1 2023 -$1.41B +$388M +21.6% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024
Q1 2022 -$1.79B +$683M +27.6% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023
Q1 2021 -$2.48B +$134M +5.13% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022
Q1 2020 -$2.61B -$245M -10.4% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021
Q1 2019 -$2.37B +$4.23B +64.1% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020
Q1 2018 -$6.6B -$5.35B -430% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019
Q1 2017 -$1.24B +$7.37B +85.6% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018
Q1 2016 -$8.61B -$5.89B -216% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017
Q1 2015 -$2.72B -$5.61B -194% 01 Jan 2015 31 Mar 2015 10-Q 06 May 2016
Q1 2014 $2.88B +$3.08B 01 Jan 2014 31 Mar 2014 10-Q 08 May 2015
Q1 2013 -$199M -$2.05B -111% 01 Jan 2013 31 Mar 2013 10-Q 07 May 2014
Q1 2012 $1.86B +$1.37B +283% 01 Jan 2012 31 Mar 2012 10-Q 08 May 2013
Q1 2011 $485M +$469M +2926% 01 Jan 2011 31 Mar 2011 10-Q 04 May 2012
Q1 2010 $16M 01 Jan 2010 31 Mar 2010 10-Q 09 May 2011

GILEAD SCIENCES, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$3.43B +$1.69B +33% 01 Jan 2024 31 Dec 2024 10-K 28 Feb 2025
2023 -$5.13B +$1.34B +20.8% 01 Jan 2023 31 Dec 2023 10-K 28 Feb 2025
2022 -$6.47B +$2.41B +27.1% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025
2021 -$8.88B -$9.65B -1253% 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2024
2020 $770M +$8.4B 01 Jan 2020 31 Dec 2020 10-K 22 Feb 2023
2019 -$7.63B +$4.68B +38% 01 Jan 2019 31 Dec 2019 10-K 23 Feb 2022
2018 -$12.3B -$15.7B -463% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021
2017 $3.39B +$13.1B 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020
2016 -$9.73B -$3.84B -65.3% 01 Jan 2016 31 Dec 2016 10-K 26 Feb 2019
2015 -$5.88B -$2.86B -94.5% 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018
2014 -$3.03B -$481M -18.9% 01 Jan 2014 31 Dec 2014 10-K 27 Feb 2017
2013 -$2.54B -$3.11B -552% 01 Jan 2013 31 Dec 2013 10-K 24 Feb 2016
2012 $563M -$1.2B -68.1% 01 Jan 2012 31 Dec 2012 10-K 25 Feb 2015
2011 $1.76B +$3.1B 01 Jan 2011 31 Dec 2011 10-K 25 Feb 2014
2010 -$1.34B 01 Jan 2010 31 Dec 2010 10-K 27 Feb 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.